Skip to main content Skip to section navigation Skip to footer
Investor Relations
VIZZ eye drops Back to lenz-tx.com
LENZ Therapeutics, Inc. IR Home
  • Overview
  • News & Events
  • Company Info
  • Financial Results
  • Stock Data
  • SEC Filings
  • Governance
  • VIZZ eye drops
  • Back to lenz-tx.com

Press Releases

News & Events

News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
  • Media
Mar 24, 2026 8:00am EDT

LENZ Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights

Mar 17, 2026 8:00am EDT

LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026

Mar 10, 2026 8:00am EDT

LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia

Feb 23, 2026 8:00am EST

LENZ Therapeutics to Present at Upcoming Investor Conferences

Jan 14, 2026 8:30am EST

LENZ Therapeutics and Sarah Jessica Parker announce the launch of “Make it VIZZable”, the VIZZ consumer campaign

Jan 07, 2026 5:08pm EST

LENZ Therapeutics Reports Fourth Quarter 2025 Preliminary Unaudited Financial Results and Recent Corporate Updates

Jan 05, 2026 8:00am EST

LENZ Therapeutics and Lunatus Announce Exclusive Commercialization Partnership for VIZZ™ in the Middle East

rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
©2026 LENZ Therapeutics, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement
  • Manage Cookie Preferences